25 XP   0   0   10

Rhythm Biosciences Ltd
Buy, Hold or Sell?

Let's analyse Rhythm Biosciences Ltd together

PenkeI guess you are interested in Rhythm Biosciences Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Rhythm Biosciences Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Rhythm Biosciences Ltd

I send you an email if I find something interesting about Rhythm Biosciences Ltd.

Quick analysis of Rhythm Biosciences Ltd (30 sec.)










What can you expect buying and holding a share of Rhythm Biosciences Ltd? (30 sec.)

How much money do you get?

How much money do you get?
A$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
A$0.01
Expected worth in 1 year
A$-0.04
How sure are you?
26.9%

+ What do you gain per year?

Total Gains per Share
A$-0.04
Return On Investment
-48.7%

For what price can you sell your share?

Current Price per Share
A$0.08
Expected price per share
A$0 - A$0.091
How sure are you?
50%

1. Valuation of Rhythm Biosciences Ltd (5 min.)




Live pricePrice per Share (EOD)

A$0.08

Intrinsic Value Per Share

A$-1.33 - A$-1.58

Total Value Per Share

A$-1.32 - A$-1.57

2. Growth of Rhythm Biosciences Ltd (5 min.)




Is Rhythm Biosciences Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$812.2k$4.7m-$1.2m-36.0%

How much money is Rhythm Biosciences Ltd making?

Current yearPrevious yearGrowGrow %
Making money-$2.3m-$2m-$351.7k-14.8%
Net Profit Margin-484.2%-6,069.7%--

How much money comes from the company's main activities?

3. Financial Health of Rhythm Biosciences Ltd (5 min.)




4. Comparing to competitors in the Diagnostics & Research industry (5 min.)




  Industry Rankings (Diagnostics & Research)  


Richest
#121 / 145

Most Revenue
#120 / 145

Most Profit
#94 / 145

Most Efficient
#126 / 145

What can you expect buying and holding a share of Rhythm Biosciences Ltd? (5 min.)

Welcome investor! Rhythm Biosciences Ltd's management wants to use your money to grow the business. In return you get a share of Rhythm Biosciences Ltd.

What can you expect buying and holding a share of Rhythm Biosciences Ltd?

First you should know what it really means to hold a share of Rhythm Biosciences Ltd. And how you can make/lose money.

Speculation

The Price per Share of Rhythm Biosciences Ltd is A$0.084. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Rhythm Biosciences Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Rhythm Biosciences Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$0.01. Based on the TTM, the Book Value Change Per Share is A$-0.01 per quarter. Based on the YOY, the Book Value Change Per Share is A$0.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Rhythm Biosciences Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps-0.01-12.9%-0.01-9.1%-0.01-6.5%0.00-5.6%0.00-4.7%
Usd Book Value Change Per Share-0.01-14.6%-0.01-8.0%0.002.8%0.00-0.9%0.000.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.01-14.6%-0.01-8.0%0.002.8%0.00-0.9%0.000.2%
Usd Price Per Share0.09-0.22-0.79-0.43-0.34-
Price to Earnings Ratio-2.03--8.49--36.24--22.70--19.55-
Price-to-Total Gains Ratio-7.17--20.86-154.39-30.58-16.73-
Price to Book Ratio26.72-18.87-43.78-40.83-30.97-
Price-to-Total Gains Ratio-7.17--20.86-154.39-30.58-16.73-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.054894
Number of shares18216
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.010.00
Usd Total Gains Per Share-0.010.00
Gains per Quarter (18216 shares)-121.79-14.38
Gains per Year (18216 shares)-487.17-57.52
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-487-4970-58-68
20-974-9840-115-126
30-1461-14710-173-184
40-1949-19580-230-242
50-2436-24450-288-300
60-2923-29320-345-358
70-3410-34190-403-416
80-3897-39060-460-474
90-4384-43930-518-532
100-4872-48800-575-590

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.03.00.00.0%0.011.00.00.0%0.019.00.00.0%0.026.00.00.0%0.026.00.00.0%
Book Value Change Per Share0.02.01.00.0%3.03.05.027.3%4.06.09.021.1%7.09.010.026.9%7.09.010.026.9%
Dividend per Share0.00.03.00.0%0.00.011.00.0%0.00.019.00.0%0.00.026.00.0%0.00.026.00.0%
Total Gains per Share0.02.01.00.0%3.03.05.027.3%4.06.09.021.1%7.09.010.026.9%7.09.010.026.9%

Fundamentals of Rhythm Biosciences Ltd

About Rhythm Biosciences Ltd

Rhythm Biosciences Limited, engages in developing and commercializing medical diagnostics technology in Australia and internationally. It develops ColoSTAT, a blood test for the early detection of colorectal cancer. The company was incorporated in 2017 and is headquartered in Parkville, Australia.

Fundamental data was last updated by Penke on 2024-04-24 19:55:06.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Rhythm Biosciences Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Rhythm Biosciences Ltd earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Rhythm Biosciences Ltd to the Diagnostics & Research industry mean.
  • A Net Profit Margin of -242.1% means that $-2.42 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Rhythm Biosciences Ltd:

  • The MRQ is -242.1%. The company is making a huge loss. -2
  • The TTM is -484.2%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-242.1%TTM-484.2%+242.1%
TTM-484.2%YOY-6,069.7%+5,585.5%
TTM-484.2%5Y-11,393.6%+10,909.4%
5Y-11,393.6%10Y-11,731.8%+338.2%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-242.1%-7.3%-234.8%
TTM-484.2%-6.7%-477.5%
YOY-6,069.7%-1.9%-6,067.8%
5Y-11,393.6%-1.5%-11,392.1%
10Y-11,731.8%-3.4%-11,728.4%
1.1.2. Return on Assets

Shows how efficient Rhythm Biosciences Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Rhythm Biosciences Ltd to the Diagnostics & Research industry mean.
  • -210.5% Return on Assets means that Rhythm Biosciences Ltd generated $-2.10 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Rhythm Biosciences Ltd:

  • The MRQ is -210.5%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -97.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-210.5%TTM-97.3%-113.1%
TTM-97.3%YOY-37.1%-60.2%
TTM-97.3%5Y-53.7%-43.6%
5Y-53.7%10Y-41.0%-12.7%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-210.5%-1.3%-209.2%
TTM-97.3%-1.3%-96.0%
YOY-37.1%-0.9%-36.2%
5Y-53.7%-0.5%-53.2%
10Y-41.0%-0.9%-40.1%
1.1.3. Return on Equity

Shows how efficient Rhythm Biosciences Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Rhythm Biosciences Ltd to the Diagnostics & Research industry mean.
  • -329.2% Return on Equity means Rhythm Biosciences Ltd generated $-3.29 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Rhythm Biosciences Ltd:

  • The MRQ is -329.2%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -144.1%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-329.2%TTM-144.1%-185.1%
TTM-144.1%YOY-43.0%-101.1%
TTM-144.1%5Y-76.0%-68.1%
5Y-76.0%10Y-57.5%-18.5%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-329.2%-0.5%-328.7%
TTM-144.1%0.2%-144.3%
YOY-43.0%-0.1%-42.9%
5Y-76.0%-1.4%-74.6%
10Y-57.5%-2.3%-55.2%

1.2. Operating Efficiency of Rhythm Biosciences Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Rhythm Biosciences Ltd is operating .

  • Measures how much profit Rhythm Biosciences Ltd makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Rhythm Biosciences Ltd to the Diagnostics & Research industry mean.
  • An Operating Margin of -344.3% means the company generated $-3.44  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Rhythm Biosciences Ltd:

  • The MRQ is -344.3%. The company is operating very inefficient. -2
  • The TTM is -562.2%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-344.3%TTM-562.2%+217.9%
TTM-562.2%YOY-6,120.7%+5,558.5%
TTM-562.2%5Y-12,713.4%+12,151.1%
5Y-12,713.4%10Y-12,381.6%-331.8%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-344.3%-7.4%-336.9%
TTM-562.2%0.5%-562.7%
YOY-6,120.7%4.0%-6,124.7%
5Y-12,713.4%3.7%-12,717.1%
10Y-12,381.6%-1.3%-12,380.3%
1.2.2. Operating Ratio

Measures how efficient Rhythm Biosciences Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • An Operation Ratio of 3.44 means that the operating costs are $3.44 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Rhythm Biosciences Ltd:

  • The MRQ is 3.443. The company is inefficient in keeping operating costs low. -1
  • The TTM is 5.622. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ3.443TTM5.622-2.179
TTM5.622YOY61.207-55.585
TTM5.6225Y127.015-121.393
5Y127.01510Y105.432+21.583
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ3.4431.280+2.163
TTM5.6221.304+4.318
YOY61.2071.236+59.971
5Y127.0151.242+125.773
10Y105.4321.205+104.227

1.3. Liquidity of Rhythm Biosciences Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Rhythm Biosciences Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A Current Ratio of 2.04 means the company has $2.04 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Rhythm Biosciences Ltd:

  • The MRQ is 2.045. The company is able to pay all its short-term debts. +1
  • The TTM is 3.370. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ2.045TTM3.370-1.325
TTM3.370YOY8.298-4.929
TTM3.3705Y6.740-3.370
5Y6.74010Y16.089-9.350
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ2.0452.122-0.077
TTM3.3702.298+1.072
YOY8.2982.599+5.699
5Y6.7403.012+3.728
10Y16.0893.081+13.008
1.3.2. Quick Ratio

Measures if Rhythm Biosciences Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Rhythm Biosciences Ltd to the Diagnostics & Research industry mean.
  • A Quick Ratio of 2.04 means the company can pay off $2.04 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Rhythm Biosciences Ltd:

  • The MRQ is 2.038. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 1.500. The company is able to pay all its short-term debts with the most liquid assets. +1
Trends
Current periodCompared to+/- 
MRQ2.038TTM1.500+0.538
TTM1.500YOY4.102-2.602
TTM1.5005Y3.477-1.978
5Y3.47710Y8.124-4.647
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ2.0381.215+0.823
TTM1.5001.319+0.181
YOY4.1021.661+2.441
5Y3.4771.957+1.520
10Y8.1242.295+5.829

1.4. Solvency of Rhythm Biosciences Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Rhythm Biosciences Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Rhythm Biosciences Ltd to Diagnostics & Research industry mean.
  • A Debt to Asset Ratio of 0.36 means that Rhythm Biosciences Ltd assets are financed with 36.1% credit (debt) and the remaining percentage (100% - 36.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Rhythm Biosciences Ltd:

  • The MRQ is 0.361. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.241. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.361TTM0.241+0.120
TTM0.241YOY0.136+0.105
TTM0.2415Y0.190+0.051
5Y0.19010Y0.156+0.033
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3610.429-0.068
TTM0.2410.407-0.166
YOY0.1360.394-0.258
5Y0.1900.450-0.260
10Y0.1560.450-0.294
1.4.2. Debt to Equity Ratio

Measures if Rhythm Biosciences Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Rhythm Biosciences Ltd to the Diagnostics & Research industry mean.
  • A Debt to Equity ratio of 56.4% means that company has $0.56 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Rhythm Biosciences Ltd:

  • The MRQ is 0.564. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.339. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.564TTM0.339+0.225
TTM0.339YOY0.157+0.181
TTM0.3395Y0.267+0.072
5Y0.26710Y0.218+0.049
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5640.606-0.042
TTM0.3390.571-0.232
YOY0.1570.631-0.474
5Y0.2670.658-0.391
10Y0.2180.734-0.516

2. Market Valuation of Rhythm Biosciences Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Rhythm Biosciences Ltd generates.

  • Above 15 is considered overpriced but always compare Rhythm Biosciences Ltd to the Diagnostics & Research industry mean.
  • A PE ratio of -2.03 means the investor is paying $-2.03 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Rhythm Biosciences Ltd:

  • The EOD is -1.263. Based on the earnings, the company is expensive. -2
  • The MRQ is -2.029. Based on the earnings, the company is expensive. -2
  • The TTM is -8.491. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.263MRQ-2.029+0.767
MRQ-2.029TTM-8.491+6.462
TTM-8.491YOY-36.235+27.745
TTM-8.4915Y-22.697+14.206
5Y-22.69710Y-19.555-3.142
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-1.263-0.239-1.024
MRQ-2.029-0.395-1.634
TTM-8.491-0.199-8.292
YOY-36.235-0.008-36.227
5Y-22.6973.483-26.180
10Y-19.5554.432-23.987
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Rhythm Biosciences Ltd:

  • The EOD is -1.650. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -2.652. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -2.500. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.650MRQ-2.652+1.002
MRQ-2.652TTM-2.500-0.152
TTM-2.500YOY-12.248+9.748
TTM-2.5005Y-108.703+106.203
5Y-108.70310Y-111.999+3.296
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-1.650-0.296-1.354
MRQ-2.652-0.441-2.211
TTM-2.500-1.480-1.020
YOY-12.248-2.079-10.169
5Y-108.703-1.665-107.038
10Y-111.999-1.971-110.028
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Rhythm Biosciences Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A PB ratio of 26.72 means the investor is paying $26.72 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Rhythm Biosciences Ltd:

  • The EOD is 16.623. Based on the equity, the company is expensive. -2
  • The MRQ is 26.716. Based on the equity, the company is expensive. -2
  • The TTM is 18.871. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD16.623MRQ26.716-10.093
MRQ26.716TTM18.871+7.845
TTM18.871YOY43.785-24.914
TTM18.8715Y40.825-21.954
5Y40.82510Y30.966+9.859
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD16.6231.962+14.661
MRQ26.7162.222+24.494
TTM18.8712.168+16.703
YOY43.7853.041+40.744
5Y40.8253.533+37.292
10Y30.9664.125+26.841
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Rhythm Biosciences Ltd.

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Rhythm Biosciences Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.019-0.010-46%0.004-632%-0.001-94%0.000-9788%
Book Value Per Share--0.0050.022-77%0.029-83%0.020-75%0.022-77%
Current Ratio--2.0453.370-39%8.298-75%6.740-70%16.089-87%
Debt To Asset Ratio--0.3610.241+50%0.136+166%0.190+90%0.156+130%
Debt To Equity Ratio--0.5640.339+67%0.157+258%0.267+111%0.218+159%
Dividend Per Share----0%-0%-0%-0%
Eps---0.017-0.012-30%-0.008-50%-0.007-57%-0.006-64%
Free Cash Flow Per Share---0.013-0.017+33%-0.013-1%-0.008-34%-0.006-49%
Free Cash Flow To Equity Per Share---0.012-0.016+31%0.007-276%-0.002-81%-0.002-81%
Gross Profit Margin--1.0171.012+1%1.033-2%1.0200%1.026-1%
Intrinsic Value_10Y_max---1.576--------
Intrinsic Value_10Y_min---1.328--------
Intrinsic Value_1Y_max---0.071--------
Intrinsic Value_1Y_min---0.069--------
Intrinsic Value_3Y_max---0.279--------
Intrinsic Value_3Y_min---0.265--------
Intrinsic Value_5Y_max---0.568--------
Intrinsic Value_5Y_min---0.521--------
Market Cap20662488.000-61%33207570.00081994000.000-60%297945697.500-89%163443387.221-80%128569114.892-74%
Net Profit Margin---2.421-4.842+100%-60.697+2407%-113.936+4607%-117.318+4746%
Operating Margin---3.443-5.622+63%-61.207+1678%-127.134+3592%-123.816+3496%
Operating Ratio--3.4435.622-39%61.207-94%127.015-97%105.432-97%
Pb Ratio16.623-61%26.71618.871+42%43.785-39%40.825-35%30.966-14%
Pe Ratio-1.263+38%-2.029-8.491+318%-36.235+1686%-22.697+1019%-19.555+864%
Price Per Share0.084-61%0.1350.333-60%1.211-89%0.664-80%0.523-74%
Price To Free Cash Flow Ratio-1.650+38%-2.652-2.500-6%-12.248+362%-108.703+3999%-111.999+4123%
Price To Total Gains Ratio-4.461+38%-7.170-20.863+191%154.389-105%30.584-123%16.734-143%
Quick Ratio--2.0381.500+36%4.102-50%3.477-41%8.124-75%
Return On Assets---2.105-0.973-54%-0.371-82%-0.537-74%-0.410-81%
Return On Equity---3.292-1.441-56%-0.430-87%-0.760-77%-0.575-83%
Total Gains Per Share---0.019-0.010-46%0.004-632%-0.001-94%0.000-9788%
Usd Book Value--812289.3913465805.229-77%4713384.761-83%3200226.578-75%3604044.960-77%
Usd Book Value Change Per Share---0.012-0.007-46%0.002-632%-0.001-94%0.000-9788%
Usd Book Value Per Share--0.0030.014-77%0.019-83%0.013-75%0.015-77%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.011-0.008-30%-0.005-50%-0.005-57%-0.004-64%
Usd Free Cash Flow---2045796.781-1814767.104-11%-1016709.745-50%-920110.149-55%-678939.178-67%
Usd Free Cash Flow Per Share---0.008-0.011+33%-0.008-1%-0.005-34%-0.004-49%
Usd Free Cash Flow To Equity Per Share---0.008-0.010+31%0.004-276%-0.002-81%-0.002-81%
Usd Market Cap13502935.908-61%21701146.99553583079.000-60%194707513.316-89%106810253.549-80%84019916.582-74%
Usd Price Per Share0.055-61%0.0880.218-60%0.792-89%0.434-80%0.342-74%
Usd Profit---2673739.049-2374093.833-11%-2022307.213-24%-1624279.848-39%-1267115.827-53%
Usd Revenue--1104509.104449835.200+146%447628.385+147%183345.788+502%141276.370+682%
Usd Total Gains Per Share---0.012-0.007-46%0.002-632%-0.001-94%0.000-9788%
 EOD+3 -5MRQTTM+13 -21YOY+6 -285Y+6 -2810Y+6 -28

4.2. Fundamental Score

Let's check the fundamental score of Rhythm Biosciences Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.263
Price to Book Ratio (EOD)Between0-116.623
Net Profit Margin (MRQ)Greater than0-2.421
Operating Margin (MRQ)Greater than0-3.443
Quick Ratio (MRQ)Greater than12.038
Current Ratio (MRQ)Greater than12.045
Debt to Asset Ratio (MRQ)Less than10.361
Debt to Equity Ratio (MRQ)Less than10.564
Return on Equity (MRQ)Greater than0.15-3.292
Return on Assets (MRQ)Greater than0.05-2.105
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Rhythm Biosciences Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5034.082
Ma 20Greater thanMa 500.092
Ma 50Greater thanMa 1000.098
Ma 100Greater thanMa 2000.116
OpenGreater thanClose0.090
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in AUD. All numbers in thousands.

Summary
Total Assets1,944
Total Liabilities701
Total Stockholder Equity1,243
 As reported
Total Liabilities 701
Total Stockholder Equity+ 1,243
Total Assets = 1,944

Assets

Total Assets1,944
Total Current Assets1,389
Long-term Assets555
Total Current Assets
Cash And Cash Equivalents 1,218
Short-term Investments 45
Net Receivables 77
Inventory 4
Other Current Assets 45
Total Current Assets  (as reported)1,389
Total Current Assets  (calculated)1,389
+/-0
Long-term Assets
Property Plant Equipment 183
Intangible Assets 372
Long-term Assets  (as reported)555
Long-term Assets  (calculated)555
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities679
Long-term Liabilities22
Total Stockholder Equity1,243
Total Current Liabilities
Short-term Debt 39
Accounts payable 573
Other Current Liabilities 67
Total Current Liabilities  (as reported)679
Total Current Liabilities  (calculated)679
+/- 0
Long-term Liabilities
Long-term Liabilities  (as reported)22
Long-term Liabilities  (calculated)0
+/- 22
Total Stockholder Equity
Common Stock31,821
Retained Earnings -35,909
Accumulated Other Comprehensive Income 5,331
Total Stockholder Equity (as reported)1,243
Total Stockholder Equity (calculated)1,243
+/-0
Other
Cash and Short Term Investments 1,263
Common Stock Shares Outstanding 225,881
Current Deferred Revenue0
Liabilities and Stockholders Equity 1,944
Net Debt -1,179
Short Long Term Debt Total 39



Balance Sheet

Currency in AUD. All numbers in thousands.

 Trend2023-12-312023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-30
> Total Assets 
1,856
9,449
9,449
8,449
8,449
7,296
7,296
6,229
6,229
4,491
4,491
0
2,646
0
6,813
0
3,070
0
6,368
0
8,438
0
10,042
0
7,695
1,944
1,9447,695010,04208,43806,36803,07006,81302,64604,4914,4916,2296,2297,2967,2968,4498,4499,4499,4491,856
   > Total Current Assets 
1,244
8,834
8,834
7,869
7,869
6,642
6,642
5,605
5,605
3,832
3,832
2,005
2,005
6,222
6,222
2,494
2,494
5,843
5,843
7,771
7,771
9,392
9,392
7,119
7,119
1,389
1,3897,1197,1199,3929,3927,7717,7715,8435,8432,4942,4946,2226,2222,0052,0053,8323,8325,6055,6056,6426,6427,8697,8698,8348,8341,244
       Cash And Cash Equivalents 
1,207
8,793
8,793
7,780
7,780
6,426
6,426
4,728
4,728
3,647
3,647
0
1,798
0
6,018
0
2,228
0
5,542
0
7,550
0
8,850
0
4,124
1,218
1,2184,12408,85007,55005,54202,22806,01801,79803,6473,6474,7284,7286,4266,4267,7807,7808,7938,7931,207
       Short-term Investments 
0
0
0
45
45
45
45
45
45
45
45
0
45
0
45
0
45
0
45
0
45
0
45
0
45
45
454504504504504504504504545454545454545000
       Net Receivables 
13
31
31
35
35
75
75
798
798
55
55
139
139
76
76
164
164
109
109
82
82
97
97
66
66
77
776666979782821091091641647676139139555579879875753535313113
       Other Current Assets 
0
11
11
0
9
0
0
0
34
0
84
0
23
0
83
0
57
0
147
0
93
0
400
0
118
45
45118040009301470570830230840340009011110
   > Long-term Assets 
0
0
0
0
579
0
0
0
624
0
659
0
641
0
591
0
576
0
525
0
667
0
650
0
576
555
555576065006670525057605910641065906240005790000
       Property Plant Equipment 
4
4
4
9
9
102
102
90
90
143
143
143
143
111
111
114
114
80
80
241
241
242
242
186
186
183
1831861862422422412418080114114111111143143143143909010210299444
       Intangible Assets 
608
611
611
570
570
552
552
534
534
516
516
0
498
0
480
0
462
0
444
0
426
0
408
0
390
372
3723900408042604440462048004980516516534534552552570570611611608
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000
> Total Liabilities 
550
119
119
147
147
407
407
380
380
547
547
0
803
0
643
0
1,363
0
1,055
0
1,066
0
1,249
0
1,821
701
7011,82101,24901,06601,05501,363064308030547547380380407407147147119119550
   > Total Current Liabilities 
550
119
119
147
147
407
407
373
373
527
527
794
794
625
625
1,343
1,343
1,018
1,018
932
932
1,137
1,137
1,766
1,766
679
6791,7661,7661,1371,1379329321,0181,0181,3431,343625625794794527527373373407407147147119119550
       Short-term Debt 
0
0
0
0
45
0
0
0
45
0
120
0
42
0
11
0
0
0
0
0
86
0
89
0
85
39
398508908600000110420120045000450000
       Accounts payable 
229
116
116
79
79
304
304
207
207
340
340
561
561
503
503
603
603
830
830
278
278
890
890
1,334
1,334
573
5731,3341,3348908902782788308306036035035035615613403402072073043047979116116229
       Other Current Liabilities 
250
0
0
9
68
25
25
0
166
67
67
0
191
0
112
137
740
188
188
0
569
0
157
0
347
67
673470157056901881887401371120191067671660252568900250
   > Long-term Liabilities 
0
0
0
0
79
0
0
0
7
0
20
0
8
0
18
0
20
0
37
0
133
0
112
0
55
22
2255011201330370200180802007000790000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
11
0
0
0
0
0
0
0
0
0
85
0
39
0
0
0
00039085000000000110000000000
       Other Liabilities 
0
0
0
0
0
0
0
7
7
10
10
8
8
18
18
20
20
37
37
49
49
73
73
55
55
0
0555573734949373720201818881010770000000
> Total Stockholder Equity
1,306
9,330
9,330
8,301
8,301
6,889
6,889
5,850
5,850
3,944
3,944
0
1,843
0
6,170
0
1,707
0
5,313
0
7,372
0
8,793
0
5,874
1,243
1,2435,87408,79307,37205,31301,70706,17001,84303,9443,9445,8505,8506,8896,8898,3018,3019,3309,3301,306
   Common Stock
1,538
10,047
10,047
10,037
10,037
10,037
10,037
10,037
10,037
10,037
10,037
10,037
10,037
15,846
15,846
15,981
15,981
21,468
21,468
27,835
27,835
31,026
31,026
31,551
31,551
31,821
31,82131,55131,55131,02631,02627,83527,83521,46821,46815,98115,98115,84615,84610,03710,03710,03710,03710,03710,03710,03710,03710,03710,03710,04710,0471,538
   Retained Earnings -35,909-31,817-31,817-27,279-27,279-23,600-23,600-19,027-19,027-14,806-14,806-10,208-10,208-8,388-8,388-6,282-6,282-4,372-4,372-3,148-3,300-1,826-1,826-718-753-231
   Capital Surplus 00000000000000000000000000
   Treasury Stock00000000000000000000000000
   Other Stockholders Equity 
0
36
36
89
89
151
151
184
184
189
189
194
194
532
532
532
532
2,872
2,872
3,137
3,137
5,047
5,047
6,141
6,141
0
06,1416,1415,0475,0473,1373,1372,8722,872532532532532194194189189184184151151898936360



Balance Sheet

Currency in AUD. All numbers in thousands.




Cash Flow

Currency in AUD. All numbers in thousands.




Income Statement

Currency in AUD. All numbers in thousands.


Latest Income Statement (annual, 2023-06-30)

Gross Profit (+$)
totalRevenue3,096
Cost of Revenue-189
Gross Profit2,9062,906
 
Operating Income (+$)
Gross Profit2,906
Operating Expense-11,542
Operating Income-11,542-8,635
 
Operating Expense (+$)
Research Development3,648
Selling General Administrative7,330
Selling And Marketing Expenses176
Operating Expense11,54211,153
 
Net Interest Income (+$)
Interest Income228
Interest Expense--
Other Finance Cost-0
Net Interest Income228
 
Pretax Income (+$)
Operating Income-11,542
Net Interest Income228
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-8,218-14,638
EBIT - interestExpense = -11,542
-8,446
-8,218
Interest Expense-
Earnings Before Interest and Taxes (EBIT)-11,542-8,218
Earnings Before Interest and Taxes (EBITDA)-11,352
 
After tax Income (+$)
Income Before Tax-8,218
Tax Provision-0
Net Income From Continuing Ops-8,218-8,218
Net Income-8,218
Net Income Applicable To Common Shares-8,218
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses11,542
Total Other Income/Expenses Net3,096-228
 

Technical Analysis of Rhythm Biosciences Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Rhythm Biosciences Ltd. The general trend of Rhythm Biosciences Ltd is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Rhythm Biosciences Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Rhythm Biosciences Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.091 < 0.091 < 0.091.

The bearish price targets are: .

Tweet this
Rhythm Biosciences Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Rhythm Biosciences Ltd. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Rhythm Biosciences Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Rhythm Biosciences Ltd. The current macd is -0.00285558.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Rhythm Biosciences Ltd price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Rhythm Biosciences Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Rhythm Biosciences Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Rhythm Biosciences Ltd Daily Moving Average Convergence/Divergence (MACD) ChartRhythm Biosciences Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Rhythm Biosciences Ltd. The current adx is 15.59.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Rhythm Biosciences Ltd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Rhythm Biosciences Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Rhythm Biosciences Ltd. The current sar is 0.09754193.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Rhythm Biosciences Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Rhythm Biosciences Ltd. The current rsi is 34.08. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Rhythm Biosciences Ltd Daily Relative Strength Index (RSI) ChartRhythm Biosciences Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Rhythm Biosciences Ltd. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Rhythm Biosciences Ltd price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Rhythm Biosciences Ltd Daily Stochastic Oscillator ChartRhythm Biosciences Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Rhythm Biosciences Ltd. The current cci is -315.22633745.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Rhythm Biosciences Ltd Daily Commodity Channel Index (CCI) ChartRhythm Biosciences Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Rhythm Biosciences Ltd. The current cmo is -41.1642546.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Rhythm Biosciences Ltd Daily Chande Momentum Oscillator (CMO) ChartRhythm Biosciences Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Rhythm Biosciences Ltd. The current willr is -100.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Rhythm Biosciences Ltd Daily Williams %R ChartRhythm Biosciences Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Rhythm Biosciences Ltd.

Rhythm Biosciences Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Rhythm Biosciences Ltd. The current atr is 0.00333188.

Rhythm Biosciences Ltd Daily Average True Range (ATR) ChartRhythm Biosciences Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Rhythm Biosciences Ltd. The current obv is -27,155,615.

Rhythm Biosciences Ltd Daily On-Balance Volume (OBV) ChartRhythm Biosciences Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Rhythm Biosciences Ltd. The current mfi is 35.07.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Rhythm Biosciences Ltd Daily Money Flow Index (MFI) ChartRhythm Biosciences Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Rhythm Biosciences Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-30STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-07CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-19MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-20STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-21STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-28MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-29MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-09STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-25STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-30DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-31BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-01ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-02STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-05STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-06ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-13WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-16STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-19STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-21CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-21CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-04-03STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-05STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-11STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-22STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).

6.3. Candlestick Patterns

Rhythm Biosciences Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Rhythm Biosciences Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5034.082
Ma 20Greater thanMa 500.092
Ma 50Greater thanMa 1000.098
Ma 100Greater thanMa 2000.116
OpenGreater thanClose0.090
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Rhythm Biosciences Ltd with someone you think should read this too:
  • Are you bullish or bearish on Rhythm Biosciences Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Rhythm Biosciences Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Rhythm Biosciences Ltd

I send you an email if I find something interesting about Rhythm Biosciences Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Rhythm Biosciences Ltd.

Receive notifications about Rhythm Biosciences Ltd in your mailbox!